Hillcrest HealthCare System’s Post

I’d like to share a nice case I did recently. A 70-year-old patient with chronic kidney disease (GFR 15 ml/min) presented with acute coronary syndrome due to acute thrombosis of an under-expanded proximal circumflex artery stent due to underlying calcified nodule , along with significant heavily calcified stenosis in the proximal left anterior descending artery. The patient had an ejection fraction of 45%. We addressed the culprit lesion first, using Shockwave intravascular lithotripsy and a non-compliant (NC) balloon, followed by stenting of the LCx. The patient returned for elective LM-LAD PCI. Orbital atherectomy was performed, achieving significant debulking and excellent luminal gain. NC and stent from LM to LAD, followed by POT, kissing balloon inflation, and a final POT. Rima Chaddad MD. MHA.

As part of the community dedicated to treating aortic disease, what does the TEVAR anniversary mean to you? “All of us in this community are seeking solutions to address aortic disease. Solutions where the benefits can prove to outweigh the risks and provide options for physicians and their patients. The aortic disease process is complex and we are all learning together – physicians, industry, societies, regulatory bodies – how to address these challenges. Given this environment, it is with pride that I celebrate the 25th anniversary of TEVAR* with my many colleagues at Gore and those we collaborate with across the therapy space. Additionally, this milestone is inspirational and encourages us all to keep innovating and striving to find solutions for increasingly complex regions of the aorta.” - Mary Mulder, Ph.D., Global Thoracic Business Leader with Gore’s Medical Products Division For indications: https://gmd.cm/lq6 * First commercial approval, CE mark February 1998. GORE® TAG® Thoracic Endoprosthesis. Post intended for distribution in the U.S. #GoreMedical #TEVAR #TEVARTriumphs #TEVARStories ________________________________________________________________ Refer to Instructions for Use at eifu.goremedical.com for a complete description of all applicable indications, warnings, precautions and contraindications for the markets where this product is available. Rx only

70 y.old patient known to have dextrocardia situs inversus, presented with inferior STEMI secondary to severe ostio-proximal dominant RCA disease. IVUS guided PCI was done : Radial 7 Fr Guiding catheter, multiple NC & cutting balloons used , then stenting was done using “the Floating ballon technique” Very good result with IVUS confirming a well positioned stent at the ostium of RCA. The best incidence for ostial RCA perpendicular projection was RAO 64 // CRA 35. This technique provided : 1- The exact landmark intersection point of aorto- ostial RCA ( same point localized by pre procedural IVUS ) 2- Excellent stability of the guiding catheter and of stent placement which was confirmed by IVUS after stent deployment. Special Thanks to Franck Digne for this creative technique and for his support. Amine Krimech Cindy Soupin Julien Moreno Centre Hospitalier Intercommunal de Villeneuve-Saint-Georges

❤️ ⌛ When every minute matters, #speed, and #accuracy of results are paramount! Clinical laboratories can improve care for patients experiencing, or at risk of cardiovascular disease. The speed and accuracy of the information your laboratory delivers are critical to improving patient outcomes and reducing the cost of care. Beckman Coulter's comprehensive cardiac diagnostics menu provides the tests your laboratory needs to support informed clinical decision-making. ❤️ ⌛ #ClinicalLaboratories #CardiovascularDiagnostics #BeckmanCoulter Follow the below link to learn more about how our comprehensive cardiac diagnostics menu can benefit your facility. https://bit.ly/3CshSNB

As part of HeartFlow’s commitment to investing in clinical evidence, we are excited to announce the expansion of the DECIDE Registry to ~20,000 patients across ~40 sites, now including asymptomatic patients and those with prior PCI. As the largest prospective study of its kind, the DECIDE Registry will provide crucial multi-site, real-world data to understand how HeartFlow Plaque Analysis influences medical management decisions and clinical outcomes for those with suspected coronary artery disease. Together, we’re paving the way to improved patient outcomes through enhanced insights and more personalized cardiovascular disease care: https://bit.ly/4dVH8fC. #HeartFlow #DECIDERegistry #HeartFlowPlaqueAnalysis #Plaque

CASE SUPPORT IN THE ANGIO SUITE   Today marks the day of the first time I had the immense pleasure of single handedly supporting a case in the angio suite where a PAD patient was treated for a long thrombotic occlusion of the superficial femoral artery and popliteal artery. Using rotational thrombectomy the physician was able to significantly increase the man’s prognosis via debulking the occluded arteries thereby restoring blood flow and detecting the culprit lesion. The underlying issue was then subsequently treated for an optimal result under the given circumstances. In an environment where the tools available to interventionalists are ever-growing in number and complexity, we are happy to lend a helping hand, providing the right tools at the right time and sharing our detailed insights into how they can help the physician achieving his intended outcome. For somebody who doesn’t have a medical degree, supporting these cases is the closest one can get to directly and immediately impacting a patients journey to recovery. Therefore, this service on-demand is gladly and swiftly provided when required! PAD - peripheral arterial disease: https://lnkd.in/dZ_z5fXB Rotational thrombectomy: https://lnkd.in/dnU2H7WT

What sets the CorVista System apart? It's a game-changer! Offering a non-invasive, point-of-care solution, it empowers physicians to assess symptomatic patients for cardiovascular disease without the use of radiation, contrast agents, injections, fasting, or exercise. Say goodbye to lengthy procedures and hello to efficient, accurate diagnostics! #medicaldevices #pointofcare #Corvista

Save your spot for tomorrow's Sepsis Alliance session, where we'll examine the role of endotoxin in the development of sepsis and septic shock. We'll examine how the body responds to elevated endotoxin levels, its role in triggering sepsis, and how measuring endotoxin activity in the bloodstream can reveal its true impact. Can targeting endotoxin removal be a viable treatment option? Don’t miss this chance to dive into these important insights! Sepsis Alliance webinar: Thursday, October 3, 2024 @ 11am PT | 2pm ET https://lnkd.in/dDT69B9a #endotoxicsepticshock #clinicaltrials #septicshock #endotoxemia #hemoadsorption

A MUST READ PAPER!!! Moderate evidence suggests that, compared with usual care, first-line intravenous methylprednisolone reduces duration of hospital stay for children with PIMS-TS. Good evidence suggests that second-line tocilizumab reduces duration of hospital stay for children with inflammation refractory to initial treatment. Neither intravenous immunoglobulin nor anakinra had any effect on duration of hospital stay compared with usual care. DOI:https://lnkd.in/dDqcgDuj

The Association for Diagnostics & Laboratory Medicine (ADLM) has released new guidance on lipid testing to enhance care for patients with cardiovascular disease. These guidelines provide clarity on lipid tests, which measure blood fats and cholesterol, crucial for assessing heart disease risk. By standardizing testing practices, the ADLM aims to ensure accurate diagnoses and timely treatment for patients. This initiative is vital in preventing severe cardiovascular events, emphasizing the importance of routine lipid testing in clinical practice. Together, we can improve patient outcomes and foster better health through informed diagnostic practices! https://lnkd.in/eTjBmaYn You can read the guidance document here: https://lnkd.in/eVbbeizk Stay informed and ahead of the curve by following Practical Patient Care on LinkedIn for the latest industry news and insights! #CardiovascularHealth #LipidTesting #PatientCare #MedicalGuidelines